SCHEDULE 13G/A
Statement of Beneficial Ownership
Avalo Therapeutics, Inc. Filed Acc 0001193125-25-283440
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X01/primary_doc.xml…